Dr. Anna Lok's Podcast

 

"Drug Resistant Hepatitis B"

The topics of discussion for this talk: What causes resistant mutations to emerge, how common a strain is it, what other clinical consequences are there, how is it managed it in those who have it, and how can it be prevented.

Get the Flash Player to see this player.


Download MP3 File   (64.8 MB, D/L Time 2.6 hours at 56Kbps )
Playing Time: 01:10:44 (hh:mm:ss)
(Released Tue, 15 Apr 2008 05:32:19 -0600)

earbuds

Dr. Anna Lok

Anna Lok, MD, is Professor of Internal Medicine and the Director of Clinical Hepatology, U. of Michigan Medical Center. Dr. Lok is a world renowned hepatologist and one of the premier leaders in hepatitis B research. She has made seminal contributions to our understanding of the natural history of hepatitis B, the role of hepatitis B virus genotypes and variants in the outcome of chronic hepatitis B infection, and the management of hepatitis B. She has published more than 250 papers on viral hepatitis and liver diseases. In addition to her research contributions, Dr. Lok has also played a major role in educating the medical community as well as the lay public on hepatitis B. In addition to hepatitis B, Dr. Lok is also actively involved in research projects on hepatitis C, liver cancer and liver transplantation, which is funded by the NIH, CDC, and various foundations. On April 12, 2008, Dr. Lok received the Hepatitis B Foundationís Distinguished Scientist Award from Nobel Prize Winner Dr. Baruch Blumberg, one of the Foundationís Co-Founders.

Podcast Source

RSS Feed

Catch Podcasts with

getmiro.com

itunes

Refer others with

add to deli.cio

add to technorati